Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human NXPH1 Protein (AC1705)
Cat.#: ACPP-1705
Specifications
Despition NXPH1 Human Recombinant SIZE 5 µg Purity > 90% (SDS-PAGE) Form Sterile Filtered clear solution. Storage Store at 4°C for 2-4 weeks. Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1494 beta Catenin Blocking Peptide (AC1494) 250 µg inquiry ACPP-1151 Recombinant HuD Protein (AC1151) 10 µg inquiry ACPP-1615 Human CRYBB1 Protein (AC1615) 5 µg inquiry ACPP-1598 Rat SIRPA Protein (AC1598) 2 µg inquiry ACPP-1513 Human FGFR2 Protein (AC1513) 2 µg inquiry ACPP-1484 Human CPE Protein (AC1484) 5 µg inquiry ACPP-1263 MAPK7 Blocking Peptide (AC1263) 250 µg inquiry ACPP-1755 Human PDGFD Protein (AC1755) 5 µg inquiry ACPP-1114 Recombinant Human NCAM1 Protein (6×His Tag) (AC1114) 50 µg inquiry ACPP-1300 GTP cyclohydrolase 1 Blocking Peptide (AC1300) 250 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket